<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d2 20140930//EN" "JATS-archivearticle1.dtd"> 
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//Springer-Verlag//DTD A++ V2.4//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName A++V2.4.dtd?><?SourceDTD.Version 2.4?><?ConverterInfo.XSLTName springer2nlmx2.xsl?><?ConverterInfo.Version 2?><front><journal-meta><journal-id journal-id-type="nlm-ta">BMC Bioinformatics</journal-id><journal-id journal-id-type="iso-abbrev">BMC Bioinformatics</journal-id><journal-title-group><journal-title>BMC Bioinformatics</journal-title></journal-title-group><issn pub-type="epub">1471-2105</issn><publisher><publisher-name>BioMed Central</publisher-name><publisher-loc>London</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">4676880</article-id><article-id pub-id-type="publisher-id">838</article-id><article-id pub-id-type="doi">10.1186/s12859-015-0838-z</article-id><article-categories><subj-group subj-group-type="heading"><subject>Software</subject></subj-group></article-categories><title-group><article-title>MRMPlus: an open source quality control and assessment tool for SRM/MRM assay development</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-9031-000X</contrib-id><name><surname>Aiyetan</surname><given-names>Paul</given-names></name><address><phone>(443) 739 5070</phone><email>paul.aytton@gmail.com</email><email>paiyeta1@jhmi.edu</email></address><xref ref-type="aff" rid="Aff1"/></contrib><contrib contrib-type="author"><name><surname>Thomas</surname><given-names>Stefani N.</given-names></name><address><email>sthoma92@jhmi.edu</email></address><xref ref-type="aff" rid="Aff1"/></contrib><contrib contrib-type="author"><name><surname>Zhang</surname><given-names>Zhen</given-names></name><address><email>zzhang7@jhmi.edu</email></address><xref ref-type="aff" rid="Aff1"/></contrib><contrib contrib-type="author"><name><surname>Zhang</surname><given-names>Hui</given-names></name><address><email>huizhang@jhu.edu</email></address><xref ref-type="aff" rid="Aff1"/></contrib><aff id="Aff1">Department of Pathology, The Johns Hopkins University School of Medicine, Robert H and Clarice Smith Building, Room 4000C, 400 North Broadway, Baltimore, MD 21287 USA </aff></contrib-group><pub-date pub-type="epub"><day>12</day><month>12</month><year>2015</year></pub-date><pub-date pub-type="pmc-release"><day>12</day><month>12</month><year>2015</year></pub-date><pub-date pub-type="collection"><year>2015</year></pub-date><volume>16</volume><elocation-id>411</elocation-id><history><date date-type="received"><day>1</day><month>7</month><year>2015</year></date><date date-type="accepted"><day>3</day><month>12</month><year>2015</year></date></history><permissions><copyright-statement>&#x000a9; Aiyetan et al. 2015</copyright-statement><license license-type="OpenAccess"><license-p><bold>Open Access</bold>This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p></license></permissions><abstract id="Abs1"><sec><title>Background</title><p>Selected and multiple reaction monitoring involves monitoring a multiplexed assay of proteotypic peptides and associated transitions in mass spectrometry runs. To describe peptide and associated transitions as stable, quantifiable, and reproducible representatives of proteins of interest, experimental and analytical validation is required. However, inadequate and disparate analytical tools and validation methods predispose assay performance measures to errors and inconsistencies.</p></sec><sec><title>Results</title><p>Implemented as a freely available, open-source tool in the platform independent Java programing language, MRMPlus computes analytical measures as recommended recently by the Clinical Proteomics Tumor Analysis Consortium Assay Development Working Group for &#x0201c;Tier 2&#x0201d; assays &#x02013; that is, non-clinical assays sufficient enough to measure changes due to both biological and experimental perturbations. Computed measures include; limit of detection, lower limit of quantification, linearity, carry-over, partial validation of specificity, and upper limit of quantification.</p></sec><sec><title>Conclusions</title><p>MRMPlus streamlines assay development analytical workflow and therefore minimizes error predisposition. MRMPlus may also be used for performance estimation for targeted assays not described by the Assay Development Working Group. MRMPlus&#x02019; source codes and compiled binaries can be freely downloaded from <ext-link ext-link-type="uri" xlink:href="https://bitbucket.org/paiyetan/mrmplusgui">https://bitbucket.org/paiyetan/mrmplusgui</ext-link> and <ext-link ext-link-type="uri" xlink:href="https://bitbucket.org/paiyetan/mrmplusgui/downloads">https://bitbucket.org/paiyetan/mrmplusgui/downloads</ext-link> respectively.</p></sec><sec><title>Electronic supplementary material</title><p>The online version of this article (doi:10.1186/s12859-015-0838-z) contains supplementary material, which is available to authorized users.</p></sec></abstract><funding-group><award-group><funding-source><institution>National Institutes of Health, National Cancer Institute, Clinical Proteomic Tumor Analysis Consortium (CPTAC)</institution></funding-source><award-id>U24CA160036</award-id><principal-award-recipient><name><surname>Zhang</surname><given-names>Hui</given-names></name></principal-award-recipient></award-group><award-group><funding-source><institution>National Institutes of Health, Early Detection Research Network</institution></funding-source><award-id>U01CA152813</award-id><principal-award-recipient><name><surname>Zhang</surname><given-names>Hui</given-names></name></principal-award-recipient></award-group><award-group><funding-source><institution>National Heart, Lung, and Blood Institute, Programs of Excellence in Glycosciences</institution></funding-source><award-id>P01HL107153</award-id><principal-award-recipient><name><surname>Zhang</surname><given-names>Hui</given-names></name></principal-award-recipient></award-group></funding-group><custom-meta-group><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#x000a9; The Author(s) 2015</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1"><title>Background</title><p>Selected or Multiple reaction monitoring (SRM and MRM) mass spectrometry is the most widely used MS-based targeted proteomic approach. In contrast to discovery proteomics [<xref ref-type="bibr" rid="CR1">1</xref>&#x02013;<xref ref-type="bibr" rid="CR6">6</xref>], targeted proteomics strategies entail limiting the number of features monitored and optimizes chromatography, instrument tuning, and acquisition methods to achieve high sensitivity [<xref ref-type="bibr" rid="CR7">7</xref>]. Its advantages over traditional low-throughput quantitative approaches such as ELISA, Western blotting, and immunohistochemistry include multiplexing, a precise relative and absolute quantification of endogenous analytes, no antibody requirement, and an ability to detect unmodified and posttranslationally modified forms of proteins [<xref ref-type="bibr" rid="CR8">8</xref>&#x02013;<xref ref-type="bibr" rid="CR13">13</xref>]. These limitations and opportunities presented by SRM/MRM are well articulated by Shi et al. [<xref ref-type="bibr" rid="CR14">14</xref>]. As surrogates to protein expression level quantification methods such as mRNA microarray and RNASeq methods fall short of an ability to detect posttranslationally modified proteins, the demand for SRM or MRM-based analytical approaches is anticipated to increase [<xref ref-type="bibr" rid="CR7">7</xref>].</p><p>Similar to parallel reaction monitoring (PRM), MRM typically involves monitoring a multiplexed assay of proteotypic peptides. However under conditions that permit high resolution and high mass accuracy, only a set of preselected transitions are monitored in MRM as opposed to all transitions in PRM [<xref ref-type="bibr" rid="CR15">15</xref>, <xref ref-type="bibr" rid="CR16">16</xref>]. An MRM assay development workflow may be broadly sub-divided into a pre-mass spectrometry acquisition phase and a post-acquisition phase. The pre-acquisition phase includes, 1) generation of target protein list, 2) selection of proteotypic peptides and 3) an experimental design step [<xref ref-type="bibr" rid="CR17">17</xref>]. The post-acquisition phase recently described by Colangelo et al [<xref ref-type="bibr" rid="CR7">7</xref>] entails four major steps; 1) peak detection, integration and quantification, 2) data quality assessment, 3) data visualization and exploratory analysis, and 4) fold change/statistical significance analysis.</p><p>Irrespective of the targeted proteomics approach employed, the complexities of media within which monitored proteotypic peptides that represent proteins of interest reside result in the somewhat unpredictable analytical behavior of peptides and transitions. Thus, it is important that experimental and analytical validation is performed to describe peptides and associated transitions as stable, quantifiable, and reproducible representatives of proteins of interest.</p><p>To standardize and validate quantifiable targeted mass spectrometry-based peptide and protein quantifications, the National Cancer Institute (NCI) National Institutes of Health through the Clinical Proteomic Tumor Analysis Consortium (CPTAC) Assay Development Working Group (ADWG) recently described guidelines, experiments and analytical measures for MRM assay characterization [<xref ref-type="bibr" rid="CR18">18</xref>]. Extending previously published guidelines and studies [<xref ref-type="bibr" rid="CR19">19</xref>, <xref ref-type="bibr" rid="CR20">20</xref>], the described guidelines ensure some levels of confidence for assayed peptides and proteins in quantitative targeted proteomics studies.</p><p>Currently available commercial, proprietary tools and open source, vendor-neutral analytical tools for post-data acquisition processing are extensively described in Cham et al [<xref ref-type="bibr" rid="CR21">21</xref>], Brusniak et al [<xref ref-type="bibr" rid="CR17">17</xref>], Colangelo et al [<xref ref-type="bibr" rid="CR7">7</xref>] and Mani et al [<xref ref-type="bibr" rid="CR19">19</xref>]. Though these tools are highly credible in addressing individual analytical challenges, we found no suitable standalone, platform-independent tool that readily implements the CPTAC ADWG&#x02019;s recommendation for the evaluation of assay performance. However, Skyline [<xref ref-type="bibr" rid="CR22">22</xref>], described as the most complete open source platform addressing a great deal of the analytical requirements of an MRM assay development protocol, provided a sufficient basis for the development of MRMPlus. Streamlining workflow (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>) and minimizing error predisposition, MRMPlus takes as input, Skyline derived preprocessed files (Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Table S1), in addition to user defined metadata files (Additional files <xref rid="MOESM2" ref-type="media">2</xref> and <xref rid="MOESM3" ref-type="media">3</xref>: Tables S2 and S3) to compute analytical and validation measures as recommended and described in the CPTAC ADWG published guidelines (<ext-link ext-link-type="uri" xlink:href="https://assays.cancer.gov/guidance-document/">https://assays.cancer.gov/guidance-document/</ext-link>).<fig id="Fig1"><label>Fig. 1</label><caption><p>MRMPlus Concept/Flow Diagram. Mass spectrometry data are first preprocessed in Skyline&#x02122; and subsequently fed as input to MRMPlus. In addition, MRMPlus takes as inputs, user-defined experiment metadata and a serial dilution information file</p></caption><graphic xlink:href="12859_2015_838_Fig1_HTML" id="MO1"/></fig></p><p>Although MRMPlus was conceptualized and implemented to compute the performance of assays developed according to guidelines established by the CPTAC Assay Development Working Group, it may also be used for performance calculations for targeted assays not described by the Working Group.</p></sec><sec id="Sec2"><title>Implementation</title><p>We implemented MRMPlus in the platform-independent Java programing language (Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2</xref>). For statistical evaluations, we utilized classes defined in the Apache Commons Mathematics library [<xref ref-type="bibr" rid="CR23">23</xref>]. For visualizations, we utilized Java classes defined in the JFreeChart library [<ext-link ext-link-type="uri" xlink:href="http://www.jfree.org/jfreechart/">http://www.jfree.org/jfreechart/</ext-link>].<fig id="Fig2"><label>Fig. 2</label><caption><p>MRMPlus&#x02019; Graphics User Interface. In addition to user-defined and Skyline input files, MRMPlus&#x02019; interface requests other program configuration options</p></caption><graphic xlink:href="12859_2015_838_Fig2_HTML" id="MO2"/></fig></p><p>Inputs to the program include Skyline-derived output files in tab-delimited format (Additional files <xref rid="MOESM1" ref-type="media">1</xref> and <xref rid="MOESM4" ref-type="media">4</xref>: Tables S1 and S4), a user defined experiment metadata (Additional file <xref rid="MOESM2" ref-type="media">2</xref>: Table S2), and a dilution information data file (Additional file <xref rid="MOESM3" ref-type="media">3</xref>: Table S3). Current implementation of MRMPlus computes analytical measures for &#x0201c;Response Curve&#x0201d; and &#x0201c;Mini-Validation of Repeatability&#x0201d; experiments according to the ADWG&#x02019;s current specifications (Additional files <xref rid="MOESM5" ref-type="media">5</xref> and <xref rid="MOESM6" ref-type="media">6</xref>: Tables S5 and S6). The response curve serves to identify the lower limit of quantification (LLOQ), the limit of detection (LOD), and the linear range of a peptide of interest in a multipoint serial dilution of a biological replicate or matrix. The mini-validation of repeatability experiments attempt to replicate peptide measurements within a complex mixture over multiple days. Its derived metrics approximate the variability of the assay in real-life practice.</p><p>Default runtime initiated interface to MRMPlus accepts inputs to compute &#x0201c;Response Curve&#x0201d; analytical measures and the &#x02018;More Options&#x02019; button instantiates the &#x0201c;Mini-Validation of Repeatability&#x0201d; module (Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2</xref>). Users may modify the configuration file (MRMPlus.config) in the application package to set runtime default options.</p><p>Setting the &#x02018;Visualize Results&#x02019; option on the &#x02018;More Options&#x02019; panel to &#x02018;TRUE&#x02019; instructs MRMPlus to generate performance associated visualizations (Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2</xref>). MRMPlus generates 8 visualization panels to provide a global perspective of assay performance across all assayed peptide transitions. In addition, MRMPlus provides peptide-specific (&#x02018;Response Curve&#x02019; and &#x02018;Repeatability&#x02019;) performance visualizations. (Additional files <xref rid="MOESM7" ref-type="media">7</xref>: Figure S1 and Additional file <xref rid="MOESM8" ref-type="media">8</xref>: Figure S2).</p><sec id="Sec3"><title>Ethics approval</title><p>The experimental work that was conducted in this study did not require ethics approval. No patient-derived specimens were used to generate the data for the development of MRMPlus. All of the data were derived from formerly N-linked glycopeptides enriched from commercially-available serum and spiked with crude peptides.</p></sec></sec><sec id="Sec4"><title>Results and discussions</title><p>To demonstrate MRMPlus&#x02019; capabilities, we employed it to compute the assay performance metrics on our panel of formerly N-linked glycopeptides. Peptides were selected from in-house discovery phase proteomic experiment analyses of prostate cancer tissues and serum studies. MRM assays to these were developed using commercially available serum and heavy labeled synthetic peptides as spiked-ins. (Please see <ext-link ext-link-type="uri" xlink:href="https://assays.cancer.gov/guidance-document/">https://assays.cancer.gov/guidance-document/</ext-link> for detailed description of experiments). Here in this case study, we subset fifteen of the profiled peptides and their respectively associated transitions for MRMPlus&#x02019; demonstration purpose.</p><p>The current implementation of MRMPlus outputs results for ADWG-defined experiments&#x02019; &#x02018;Response Curve&#x02019; and &#x02018;Mini-Validation of Repeatability&#x02019;. For &#x02018;Response Curve&#x02019; estimations, our assay experiments were performed in triplicates over seven dilution ranges (Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3</xref>). For &#x02018;Mini-validation of Repeatability&#x02019; assay experiments were similarly performed in triplicates, at three dilution (concentration) levels &#x02013; &#x0201c;High&#x0201d;, &#x0201c;Medium&#x0201d;, and &#x0201c;Low&#x0201d;. These were repeated on five different days (Fig.&#x000a0;<xref rid="Fig4" ref-type="fig">4</xref>). In both &#x02018;Response Curve&#x02019; and &#x02018;Mini-validation of Repeatability&#x02019;, we assessed three transitions for each peptide.<fig id="Fig3"><label>Fig. 3</label><caption><p>MRMPlus&#x02018; Visualization &#x02013; Response Curve. For each monitored transition of a particular peptide, experimental values are derived at serial dilution levels (calibration points). Experiments at respective dilution level are performed in replicates. Figure shows MRMPlus-generated response curves for a sample peptide &#x02013; EDALNETR. It includes performance plots for the peptide associated transitions (2.y4.1, 2.y5.1, and 2.y6.1) and summed transition</p></caption><graphic xlink:href="12859_2015_838_Fig3_HTML" id="MO3"/></fig><fig id="Fig4"><label>Fig. 4</label><caption><p>MRMPlus&#x02018; Visualization &#x02013; Mini-validation of Repeatability. For each monitored transition, low, medium and high concentration assays are profiled over five days with replicate experiments on each day. Figure shows MRMPlus-generated &#x02018;repeatability&#x02019; performance for a sample peptide &#x02013; EDALNETR. It includes performance plots for the summed transition at the a low, medium and high concentration level. Y-axis coordinates are median estimate of replicate measurements at the different concentration levels while the X-axis coordinates are the days when the experiments were performed. Current implementation of MRMPlus [by default] generates repeatability performance plot for peptides summed transition</p></caption><graphic xlink:href="12859_2015_838_Fig4_HTML" id="MO4"/></fig></p><p>MRMPlus computes performance estimates on two levels for each targeted peptide: 1) each associated transition level and 2) the summation observed transition values. Computed results are presented in tables in which the rows are performance measures for the respectively assayed peptide transition, and the columns are the computed measures of analytical performance. (Additional file <xref rid="MOESM5" ref-type="media">5</xref>: Table S5, and Additional file <xref rid="MOESM6" ref-type="media">6</xref>: Table S6). It should be noted that no absolute values are reported when the peptide transition values are summed with respect to &#x02018;PVSpec.maxDeviation&#x02019;, &#x02018;PVSpec.meanAtMaxDev&#x02019;, &#x02018;PVSpec.dayAtMaxDev&#x02019;, and &#x02018;PVSpec.concLevelAtMaxDev&#x02019; performance measures, because these are specific to transitions.</p><p>For &#x02018;Response Curve&#x02019; performances, limit of detection across peptide transitions span several magnitudes with minimum LOD reported as 0.000524, and maximum reported as 2293.62 (Additional file <xref rid="MOESM5" ref-type="media">5</xref>: Table S5, &#x02018;LOD.value&#x02019; column). In all cases, LOD was assessed using spiked-in concentrations (Additional file <xref rid="MOESM5" ref-type="media">5</xref>: Table S5, &#x02018;LOD.usedSpiked&#x02019; column) as pre-curve blank mass spectrometry runs reported no detectable levels. This is possibly due to the mass spectrometer's sensitivity or resolving power. A lower of limit of quantification (Additional file <xref rid="MOESM5" ref-type="media">5</xref>: Table S5, &#x02018;LLOQ.CaliPoint&#x02019; column) could not be estimated for peptide transitions YLGNATAIFFLPDEGK (2.b9.1), AGPNGTLFVADAYK (2.y10.1), and INNTHALVSLLQNLNK (3.b6.1). We observed an almost absolutely linear response across all transitions (Additional file <xref rid="MOESM5" ref-type="media">5</xref>: Table S5, &#x02018;Curve.Rsquared&#x02019; and &#x02018;Curve.SlopeStdErr(%)&#x02019; columns) with minimum standard error percent of the slope of the response curve reported as 0.0030&#x000a0;% and maximum as 4.3979&#x000a0;%.</p><p>For &#x02018;Mini-Validation of Repeatability&#x02019;, MRMPlus reports the intra-assay coefficient of variation, inter-assay coefficient of variation, and the total coefficient of variation for each peptide transition at respectively specified low, medium, and high concentration levels. The lowest total CV at the validated lower limit of quantification 3.3918 was found associated with peptide transition YLGNATAIFFLPDEGK (2.y8.1) (Additional file <xref rid="MOESM6" ref-type="media">6</xref>: Table S6, &#x02018;ValidatedLLOQ.concLevel&#x02019; and &#x02018;totalCV.Me&#x02019; columns).</p><p>The CPTAC ADWG recommends that for a transition to be deemed specific to a peptide, in all samples above the lower limit of quantification, no transition ratio (ratios of peak areas of different transitions of same peptide) in each sample at all concentrations should deviate &#x0003e;30&#x000a0;% from the mean. MRMPlus reports the maximum deviation percentage observed for each transition; such that a deviation above the specified 30&#x000a0;% indicates non-specificity of such transition to the associated peptide.</p><p>Thomas et al. [<xref ref-type="bibr" rid="CR24">24</xref>] &#x02013; recently published, provides a complete description of a study of ours demonstrating the utility of MRMPlus.</p><sec id="Sec5"><title>Comparing MRMPlus to PanoramaWeb</title><p>We compared MRMPlus&#x02019; results with comparable outputs derived from PanoramaWeb [<xref ref-type="bibr" rid="CR25">25</xref>] on our data (Additional file <xref rid="MOESM9" ref-type="media">9</xref>: Table S7 and Additional file <xref rid="MOESM10" ref-type="media">10</xref>: Table S8). MRMPlus and PanoramaWeb derived exactly the same results for estimation of &#x02018;Repeatability&#x02019; performance. With respect to &#x02018;Response Curve&#x02019; performance estimation MRMPlus&#x02019; and PanoramaWeb results varied. These may particularly be due to their differing methods of estimating linearity. However, Both MRMPlus&#x02019; and PanoramaWeb report excellent statistical measure of how close their data are fitted to the regression line &#x02013; indicated by similar R-squared estimation.</p></sec></sec><sec id="Sec6"><title>Conclusions</title><p>MRMPlus facilitates MRM assay development. By aligning its workflow with Skyline, a previously established tool for building, analyzing, and refining targeted mass spectrometry methods and the resulting data, MRMPlus streamlines and simplifies assay performance estimation. Future developments of MRMPlus are anticipated to be integrated to the Skyline open-source tool for an even more streamlined analytical workflow.</p></sec><sec id="Sec7"><title>Availability and requirements</title><p><bold>Project home:</bold><ext-link ext-link-type="uri" xlink:href="https://bitbucket.org/paiyetan/mrmplusgui">https://bitbucket.org/paiyetan/mrmplusgui</ext-link>, and <ext-link ext-link-type="uri" xlink:href="https://bitbucket.org/paiyetan/mrmplusgui/downloads">https://bitbucket.org/paiyetan/mrmplusgui/downloads</ext-link></p><p><bold>Operating system:</bold> Platform independent</p><p><bold>Programming Language:</bold> Java</p><p><bold>License:</bold> The BSD 3-Clause License</p><p><bold>Other requirements:</bold> Please see documentation here - <ext-link ext-link-type="uri" xlink:href="https://bitbucket.org/paiyetan/mrmplusgui/wiki/Home">https://bitbucket.org/paiyetan/mrmplusgui/wiki/Home</ext-link>.</p><p><bold>Any restrictions to use by non-academics:</bold> None</p></sec></body><back><app-group><app id="App1"><sec id="Sec8"><title>Additional files</title><p><media position="anchor" xlink:href="12859_2015_838_MOESM1_ESM.txt" id="MOESM1"><label>Additional file 1: Table S1.</label><caption><p>Sample Skyline-derived response curve experiment input to MRMPlus. (TXT 128&#x000a0;kb)</p></caption></media><media position="anchor" xlink:href="12859_2015_838_MOESM2_ESM.txt" id="MOESM2"><label>Additional file 2: Table S2.</label><caption><p>Sample user-defined response experiment metadata file. (TXT 1&#x000a0;kb)</p></caption></media><media position="anchor" xlink:href="12859_2015_838_MOESM3_ESM.txt" id="MOESM3"><label>Additional file 3: Table S3.</label><caption><p>Sample user-defined dilution file. (TXT 130 bytes)</p></caption></media><media position="anchor" xlink:href="12859_2015_838_MOESM4_ESM.txt" id="MOESM4"><label>Additional file 4: Table S4.</label><caption><p>Sample Skyline-derived repeatability experiment input to MRMPlus. (TXT 199&#x000a0;kb)</p></caption></media><media position="anchor" xlink:href="12859_2015_838_MOESM5_ESM.txt" id="MOESM5"><label>Additional file 5: Table S5.</label><caption><p>Sample MRMPlus computed assay performance metrics for the response curve experiments. (TXT 28&#x000a0;kb)</p></caption></media><media position="anchor" xlink:href="12859_2015_838_MOESM6_ESM.txt" id="MOESM6"><label>Additional file 6: Table S6.</label><caption><p>Sample MRMPlus computed assay performance metrics for assay repeatability experiments. (TXT 13&#x000a0;kb)</p></caption></media><media position="anchor" xlink:href="12859_2015_838_MOESM7_ESM.png" id="MOESM7"><label>Additional file 7: Figure S1.</label><caption><p>MRMPlus visualizations. (PNG 176&#x000a0;kb)</p></caption></media><media position="anchor" xlink:href="12859_2015_838_MOESM8_ESM.png" id="MOESM8"><label>Additional file 8: Figure S2.</label><caption><p>MRMPlus visualization showing a sample global performance view across all assayed peptide transitions. The x-axis represents individual peptide transitions (including summed transitions). The y-axis represent the computed coefficient of variations (inter-assay, intra-assay, and total) at a median level concentration. (PNG 67&#x000a0;kb)</p></caption></media><media position="anchor" xlink:href="12859_2015_838_MOESM9_ESM.xlsx" id="MOESM9"><label>Additional file 9: Table S7.</label><caption><p>Comparing and contrasting &#x02018;Repeatability&#x02019; measures between MRMPlus and PanoramaWeb. (XLSX 9&#x000a0;kb)</p></caption></media><media position="anchor" xlink:href="12859_2015_838_MOESM10_ESM.xlsx" id="MOESM10"><label>Additional file 10: Table S8.</label><caption><p>Comparing and contrasting &#x02018;Response&#x02019; measures between MRMPlus and PanoramaWeb. (XLSX 9&#x000a0;kb)</p></caption></media></p></sec></app></app-group><fn-group><fn><p><bold>Competing interests</bold></p><p>The authors have declared no financial/commercial conflict of interest.</p></fn><fn><p><bold>Authors&#x02019; contributions</bold></p><p>PA and SNT proposed the tool. PA wrote the program codes and performed analysis. SNT performed the experiments. PA and SNT tested the tool. ZZ and HZ supervised. PA drafted the manuscript and all authors reviewed and approved manuscript.</p></fn></fn-group><ack><title>Acknowledgements</title><p>The authors acknowledge all the members of the Center for Biomarker Discovery and Translation, Johns Hopkins Medical Institution; and members of the Assay Development Working Group (ADWG) of the National Cancer Institute (NCI) Clinical Proteomics Tumor Analysis Consortium (CPTAC). MRMPlus&#x02019; development was supported by the National Institutes of Health, National Cancer Institute, Clinical Proteomic Tumor Analysis Consortium (CPTAC, U24CA160036) ; the Early Detection Research Network (EDRN, U01CA152813); and the National Heart, Lung, and Blood Institute, Programs of Excellence in Glycosciences (PEG, P01HL107153). The authors also acknowledge the help of Jeffrey Whiteaker, Ph.D., of the Fred Hutchinson Cancer Research Center in Seattle, Washington, with deriving comparable performance results on PanoramaWeb.</p></ack><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Washburn</surname><given-names>MP</given-names></name><name><surname>Wolters</surname><given-names>D</given-names></name><name><surname>Yates</surname><given-names>JR</given-names></name></person-group><article-title>Large-scale analysis of the yeast proteome by multidimensional protein identification technology</article-title><source>Nat Biotechnol</source><year>2001</year><volume>19</volume><issue>3</issue><fpage>242</fpage><pub-id pub-id-type="doi">10.1038/85686</pub-id><?supplied-pmid 11231557?><pub-id pub-id-type="pmid">11231557</pub-id></element-citation></ref><ref id="CR2"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>&#x000dc;nl&#x000fc;</surname><given-names>M</given-names></name><name><surname>Morgan</surname><given-names>ME</given-names></name><name><surname>Minden</surname><given-names>JS</given-names></name></person-group><article-title>Difference gel electrophoresis. A single gel method for detecting changes in protein extracts</article-title><source>Electrophoresis</source><year>1997</year><volume>18</volume><issue>11</issue><fpage>2071</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.1002/elps.1150181133</pub-id><?supplied-pmid 9420172?><pub-id pub-id-type="pmid">9420172</pub-id></element-citation></ref><ref id="CR3"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gygi</surname><given-names>SP</given-names></name><name><surname>Rist</surname><given-names>B</given-names></name><name><surname>Gerber</surname><given-names>SA</given-names></name><name><surname>Turecek</surname><given-names>F</given-names></name><name><surname>Gelb</surname><given-names>MH</given-names></name><name><surname>Aebersold</surname><given-names>R</given-names></name></person-group><article-title>Quantitative analysis of complex protein mixtures using isotope-coded affinity tags</article-title><source>Nat Biotechnol</source><year>1999</year><volume>17</volume><issue>10</issue><fpage>994</fpage><pub-id pub-id-type="doi">10.1038/13690</pub-id><?supplied-pmid 10504701?><pub-id pub-id-type="pmid">10504701</pub-id></element-citation></ref><ref id="CR4"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ross</surname><given-names>PL</given-names></name><name><surname>Huang</surname><given-names>YN</given-names></name><name><surname>Marchese</surname><given-names>JN</given-names></name><name><surname>Williamson</surname><given-names>B</given-names></name><name><surname>Parker</surname><given-names>K</given-names></name><name><surname>Hattan</surname><given-names>S</given-names></name><etal/></person-group><article-title>Multiplexed protein quantitation in saccharomyces cerevisiae using amine-reactive isobaric tagging reagents</article-title><source>Mol Cell Proteomics</source><year>2004</year><volume>3</volume><issue>12</issue><fpage>1154</fpage><lpage>69</lpage><pub-id pub-id-type="doi">10.1074/mcp.M400129-MCP200</pub-id><?supplied-pmid 15385600?><pub-id pub-id-type="pmid">15385600</pub-id></element-citation></ref><ref id="CR5"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ong</surname><given-names>SE</given-names></name><name><surname>Blagoev</surname><given-names>B</given-names></name><name><surname>Kratchmarova</surname><given-names>I</given-names></name><name><surname>Kristensen</surname><given-names>DB</given-names></name><name><surname> Steen</surname><given-names>H</given-names></name><name><surname>Pandey</surname><given-names>A</given-names></name><etal/></person-group><article-title>Stable isotope labeling by amino acids in cell culture, SILAC, as a simple and accurate approach to expression proteomics</article-title><source>Mol. Cell. Proteomics</source><year>2002</year><volume>1</volume><issue>5</issue><fpage>376</fpage><pub-id pub-id-type="doi">10.1074/mcp.M200025-MCP200</pub-id><?supplied-pmid 12118079?><pub-id pub-id-type="pmid">12118079</pub-id></element-citation></ref><ref id="CR6"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Asara</surname><given-names>JM</given-names></name><name><surname>Christofk</surname><given-names>HR</given-names></name><name><surname>Freimark</surname><given-names>LM</given-names></name><name><surname>Cantley</surname><given-names>LC</given-names></name></person-group><article-title>A label-free quantification method by MS/MS TIC compared to SILAC and spectral counting in a proteomics screen</article-title><source>Proteomics</source><year>2008</year><volume>8</volume><issue>5</issue><fpage>994</fpage><pub-id pub-id-type="doi">10.1002/pmic.200700426</pub-id><?supplied-pmid 18324724?><pub-id pub-id-type="pmid">18324724</pub-id></element-citation></ref><ref id="CR7"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Colangelo</surname><given-names>CM</given-names></name><name><surname>Chung</surname><given-names>L</given-names></name><name><surname>Bruce</surname><given-names>C</given-names></name><name><surname>Cheung</surname><given-names>K</given-names></name></person-group><article-title>Review of software tools for design and analysis of large scale MRM proteomic datasets</article-title><source>Methods</source><year>2013</year><volume>61</volume><issue>3</issue><fpage>287</fpage><pub-id pub-id-type="doi">10.1016/j.ymeth.2013.05.004</pub-id><?supplied-pmid 23702368?><pub-id pub-id-type="pmid">23702368</pub-id></element-citation></ref><ref id="CR8"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liebler</surname><given-names>DC</given-names></name><name><surname>Zimmerman</surname><given-names>LJ</given-names></name></person-group><article-title>Targeted quantitation of proteins by mass spectrometry</article-title><source>Biochemistry (N Y )</source><year>2013</year><volume>52</volume><issue>22</issue><fpage>3797</fpage><pub-id pub-id-type="doi">10.1021/bi400110b</pub-id></element-citation></ref><ref id="CR9"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lange</surname><given-names>V</given-names></name><name><surname>Malmstr&#x000f6;m</surname><given-names>JA</given-names></name><name><surname>Didion</surname><given-names>J</given-names></name><name><surname>King</surname><given-names>NL</given-names></name><name><surname>Johansson</surname><given-names>BP</given-names></name><name><surname>Sch&#x000e4;fer</surname><given-names>J</given-names></name><etal/></person-group><article-title>Targeted quantitative analysis of streptococcus pyogenes virulence factors by multiple reaction monitoring</article-title><source>Mol. Cell. Proteomics</source><year>2008</year><volume>7</volume><issue>8</issue><fpage>1489</fpage><pub-id pub-id-type="doi">10.1074/mcp.M800032-MCP200</pub-id><?supplied-pmid 18408245?><pub-id pub-id-type="pmid">18408245</pub-id></element-citation></ref><ref id="CR10"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pan</surname><given-names>S</given-names></name><name><surname>Aebersold</surname><given-names>R</given-names></name><name><surname>Chen</surname><given-names>R</given-names></name><name><surname>Rush</surname><given-names>J</given-names></name><name><surname>Goodlett</surname><given-names>DR</given-names></name><name><surname>McIntosh</surname><given-names>MW</given-names></name><etal/></person-group><article-title>Mass spectrometry based targeted protein quantification: Methods and applications</article-title><source>J Proteome Res</source><year>2009</year><volume>8</volume><issue>2</issue><fpage>787</fpage><pub-id pub-id-type="doi">10.1021/pr800538n</pub-id><?supplied-pmid 19105742?><pub-id pub-id-type="pmid">19105742</pub-id></element-citation></ref><ref id="CR11"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Picotti</surname><given-names>P</given-names></name><name><surname>Aebersold</surname><given-names>R</given-names></name></person-group><article-title>Selected reaction monitoring-based proteomics: Workflows, potential, pitfalls and future directions</article-title><source>Nat Methods</source><year>2012</year><volume>9</volume><issue>6</issue><fpage>555</fpage><pub-id pub-id-type="doi">10.1038/nmeth.2015</pub-id><?supplied-pmid 22669653?><pub-id pub-id-type="pmid">22669653</pub-id></element-citation></ref><ref id="CR12"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kondrat</surname><given-names>RW</given-names></name><name><surname>McClusky</surname><given-names>GA</given-names></name><name><surname>Cooks</surname><given-names>RG</given-names></name></person-group><article-title>Multiple reaction monitoring in mass spectrometry/mass spectrometry for direct analysis of complex mixtures</article-title><source>Anal Chem</source><year>1978</year><volume>50</volume><issue>14</issue><fpage>2017</fpage><lpage>21</lpage><pub-id pub-id-type="doi">10.1021/ac50036a020</pub-id></element-citation></ref><ref id="CR13"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Domon</surname><given-names>B</given-names></name><name><surname>Aebersold</surname><given-names>R</given-names></name></person-group><article-title>Mass spectrometry and protein analysis</article-title><source>Science (New York, NY)</source><year>2006</year><volume>312</volume><issue>5771</issue><fpage>212</fpage><pub-id pub-id-type="doi">10.1126/science.1124619</pub-id></element-citation></ref><ref id="CR14"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shi</surname><given-names>T</given-names></name><name><surname>Su</surname><given-names>D</given-names></name><name><surname>Liu</surname><given-names>T</given-names></name><name><surname>Tang</surname><given-names>K</given-names></name><name><surname>Camp</surname><given-names>DG</given-names></name><name><surname>Qian</surname><given-names>WJ</given-names></name><etal/></person-group><article-title>Advancing the sensitivity of selected reaction monitoring&#x02010;based targeted quantitative proteomics</article-title><source>Proteomics</source><year>2012</year><volume>12</volume><issue>8</issue><fpage>1074</fpage><lpage>92</lpage><pub-id pub-id-type="doi">10.1002/pmic.201100436</pub-id><?supplied-pmid 22577010?><pub-id pub-id-type="pmid">22577010</pub-id></element-citation></ref><ref id="CR15"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lange</surname><given-names>V</given-names></name><name><surname>Picotti</surname><given-names>P</given-names></name><name><surname>Domon</surname><given-names>B</given-names></name><name><surname>Aebersold</surname><given-names>R</given-names></name></person-group><article-title>Selected reaction monitoring for quantitative proteomics: A tutorial</article-title><source>Mol Syst Biol</source><year>2008</year><volume>4</volume><fpage>222</fpage><pub-id pub-id-type="doi">10.1038/msb.2008.61</pub-id><?supplied-pmid 18854821?><pub-id pub-id-type="pmid">18854821</pub-id></element-citation></ref><ref id="CR16"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peterson</surname><given-names>AC</given-names></name><name><surname>Russell</surname><given-names>JD</given-names></name><name><surname>Bailey</surname><given-names>DJ</given-names></name><name><surname>Westphall</surname><given-names>MS</given-names></name><name><surname>Coon</surname><given-names>JJ</given-names></name></person-group><article-title>Parallel reaction monitoring for high resolution and high mass accuracy quantitative, targeted proteomics</article-title><source>Mol. Cell. Proteomics</source><year>2012</year><volume>11</volume><issue>11</issue><fpage>1475</fpage><pub-id pub-id-type="doi">10.1074/mcp.O112.020131</pub-id><?supplied-pmid 22865924?><pub-id pub-id-type="pmid">22865924</pub-id></element-citation></ref><ref id="CR17"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brusniak</surname><given-names>MY</given-names></name><name><surname>Chu</surname><given-names>CS</given-names></name><name><surname>Kusebauch</surname><given-names>U</given-names></name><name><surname>Sartain</surname><given-names>MJ</given-names></name><name><surname>Watts</surname><given-names>JD</given-names></name><name><surname>Moritz</surname><given-names>RL</given-names></name></person-group><article-title>An assessment of current bioinformatic solutions for analyzing LC-MS data acquired by selected reaction monitoring technology</article-title><source>Proteomics</source><year>2012</year><volume>12</volume><issue>8</issue><fpage>1176</fpage><pub-id pub-id-type="doi">10.1002/pmic.201100571</pub-id><?supplied-pmid 22577019?><pub-id pub-id-type="pmid">22577019</pub-id></element-citation></ref><ref id="CR18"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Whiteaker</surname><given-names>JR</given-names></name><name><surname>Halusa</surname><given-names>GN</given-names></name><name><surname>Hoofnagle</surname><given-names>AN</given-names></name><name><surname>Sharma</surname><given-names>V</given-names></name><name><surname>MacLean</surname><given-names>B</given-names></name><name><surname>Yan</surname><given-names>P</given-names></name><etal/></person-group><article-title>CPTAC assay portal: A repository of targeted proteomic assays</article-title><source>Nat Methods</source><year>2014</year><volume>11</volume><issue>7</issue><fpage>703</fpage><pub-id pub-id-type="doi">10.1038/nmeth.3002</pub-id><?supplied-pmid 24972168?><pub-id pub-id-type="pmid">24972168</pub-id></element-citation></ref><ref id="CR19"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mani</surname><given-names>DR</given-names></name><name><surname>Abbatiello</surname><given-names>SE</given-names></name><name><surname>Carr</surname><given-names>SA</given-names></name></person-group><article-title>Statistical characterization of multiple-reaction monitoring mass spectrometry (MRM-MS) assays for quantitative proteomics</article-title><source>BMC Bioinformatics</source><year>2012</year><volume>13</volume><fpage>1</fpage><pub-id pub-id-type="doi">10.1186/1471-2105-13-S16-S9</pub-id><pub-id pub-id-type="pmid">22214541</pub-id></element-citation></ref><ref id="CR20"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carr</surname><given-names>SA</given-names></name><name><surname>Abbatiello</surname><given-names>SE</given-names></name><name><surname>Ackermann</surname><given-names>BL</given-names></name><name><surname>Borchers</surname><given-names>C</given-names></name><name><surname>Domon</surname><given-names>B</given-names></name><name><surname>Deutsch</surname><given-names>EW</given-names></name><etal/></person-group><article-title>Targeted peptide measurements in biology and medicine: Best practices for mass spectrometry-based assay development using a fit-for-purpose approach</article-title><source>Mol. Cell. Proteomics</source><year>2014</year><volume>13</volume><issue>3</issue><fpage>907</fpage><pub-id pub-id-type="doi">10.1074/mcp.M113.036095</pub-id><?supplied-pmid 24443746?><pub-id pub-id-type="pmid">24443746</pub-id></element-citation></ref><ref id="CR21"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cham Mead</surname><given-names>JA</given-names></name><name><surname>Bianco</surname><given-names>L</given-names></name><name><surname>Bessant</surname><given-names>C</given-names></name></person-group><article-title>Free computational resources for designing selected reaction monitoring transitions</article-title><source>Proteomics</source><year>2010</year><volume>10</volume><issue>6</issue><fpage>1106</fpage><pub-id pub-id-type="doi">10.1002/pmic.200900396</pub-id><?supplied-pmid 20077412?><pub-id pub-id-type="pmid">20077412</pub-id></element-citation></ref><ref id="CR22"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>MacLean</surname><given-names>B</given-names></name><name><surname>Tomazela</surname><given-names>DM</given-names></name><name><surname>Shulman</surname><given-names>N</given-names></name><name><surname>Chambers</surname><given-names>M</given-names></name><name><surname>Finney</surname><given-names>GL</given-names></name><name><surname>Frewen</surname><given-names>B</given-names></name><etal/></person-group><article-title>Skyline: An open source document editor for creating and analyzing targeted proteomics experiments</article-title><source>Bioinformatics</source><year>2010</year><volume>26</volume><issue>7</issue><fpage>966</fpage><pub-id pub-id-type="doi">10.1093/bioinformatics/btq054</pub-id><?supplied-pmid 20147306?><pub-id pub-id-type="pmid">20147306</pub-id></element-citation></ref><ref id="CR23"><label>23.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Math</surname><given-names>C</given-names></name></person-group><source>The Apache Commons Mathematics Library</source><year>2014</year></element-citation></ref><ref id="CR24"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thomas</surname><given-names>SN</given-names></name><name><surname>Harlan</surname><given-names>R</given-names></name><name><surname>Chen</surname><given-names>J</given-names></name><name><surname>Aiyetan</surname><given-names>P</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Sokoll</surname><given-names>LJ</given-names></name><etal/></person-group><article-title>Multiplexed Targeted Mass Spectrometry-Based Assays for the Quantification of N-Linked Glycosite-Containing Peptides in Serum</article-title><source>Anal Chem</source><year>2015</year><volume>87</volume><issue>21</issue><fpage>10830</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1021/acs.analchem.5b02063</pub-id><?supplied-pmid 26451657?><pub-id pub-id-type="pmid">26451657</pub-id></element-citation></ref><ref id="CR25"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sharma</surname><given-names>V</given-names></name><name><surname>Eckels</surname><given-names>J</given-names></name><name><surname>Taylor</surname><given-names>GK</given-names></name><name><surname>Shulman</surname><given-names>NJ</given-names></name><name><surname>Stergachis</surname><given-names>AB</given-names></name><name><surname>Joyner</surname><given-names>SA</given-names></name><etal/></person-group><article-title>Panorama: a targeted proteomics knowledge base</article-title><source>J Proteome Res</source><year>2014</year><volume>13</volume><issue>9</issue><fpage>4205</fpage><lpage>10</lpage><pub-id pub-id-type="doi">10.1021/pr5006636</pub-id><?supplied-pmid 25102069?><pub-id pub-id-type="pmid">25102069</pub-id></element-citation></ref></ref-list></back></article>